BioLineRx Ltd. financial data

Symbol
BLRX on Nasdaq
Location
Modi In
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 31 Mar 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,232,601,990 shares

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense $2,225,000 USD -26%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets $38,906,000 USD -39%
Liabilities $25,445,000 USD -50%